Search
Search Results
##search.searchResults.foundPlural##
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2111PDF: 873HTML: 354 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1630PDF: 1076HTML: 420 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2311PDF: 1006HTML: 2220 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
841PDF: 551HTML: 4026 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3812PDF: 1513HTML: 320 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7766PDF: 2463HTML: 2103Table 1.: 234Table 2.: 244Table 3.: 226Table 4.: 219 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3463PDF: 1321HTML: 2301Fi.1 Gritti.Rambaldi: 222 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2046PDF: 755HTML: 716Table1: patient's characteristics: 167Table 2: profile of each patient: 191 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2610PDF: 1204HTML: 151 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1129PDF: 573Suppl. Files: 135HTML: 409 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1821PDF: 1012HTML: 1834Tables: 190 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1106PDF: 1204Suppl. Files: 582HTML: 95 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
544PDF: 273HTML: 106 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4191Suppl. Files: 1197PDF: 1114Html: 246 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1929PDF: 1193HTML: 332 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
216PDF: 331Suppl. Files: 58HTML: 106 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2894PDF: 1042HTML: 5631 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2174PDF: 1342HTML: 3509 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2313PDF: 1006HTML: 4972 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1137PDF: 890HTML: 280 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4462PDF: 940HTML: 1357Table1: 194 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2547PDF: 976HTML: 2249 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4627PDF: 1972HTML: 18045 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2678PDF: 1657HTML: 2440Table1: 206 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
145PDF: 460HTML: 45 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2973PDF: 1398HTML: 3719Untitled: 208Untitled: 221Untitled: 195 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1539PDF: 913HTML: 377 -
WHAT ARE FUNGAL INFECTIONS?
4297PDF: 2449HTML: 27656de Pauw: 256 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2087PDF: 832HTML: 1100 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2040PDF: 1266HTML: 792 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12770PDF: 1712HTML: 4342Cover letter: 212Figure 1: 219 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2974PDF: 1369HTML: 166







